PharVision Advisers LLC bought a new position in shares of Ingredion Incorporated (NYSE:INGR - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 1,871 shares of the company's stock, valued at approximately $257,000.
Other institutional investors and hedge funds have also recently modified their holdings of the company. BOK Financial Private Wealth Inc. acquired a new position in Ingredion in the fourth quarter valued at approximately $25,000. Migdal Insurance & Financial Holdings Ltd. acquired a new position in shares of Ingredion during the 4th quarter worth approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in shares of Ingredion by 653.3% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 226 shares of the company's stock worth $31,000 after buying an additional 196 shares during the period. EverSource Wealth Advisors LLC raised its stake in shares of Ingredion by 32.4% during the 4th quarter. EverSource Wealth Advisors LLC now owns 323 shares of the company's stock worth $44,000 after buying an additional 79 shares during the period. Finally, Crews Bank & Trust acquired a new position in shares of Ingredion during the 4th quarter worth approximately $48,000. Institutional investors and hedge funds own 85.27% of the company's stock.
Analyst Upgrades and Downgrades
Several research analysts recently commented on INGR shares. BMO Capital Markets reduced their price objective on Ingredion from $147.00 to $133.00 and set a "market perform" rating for the company in a research note on Wednesday, February 5th. Stephens dropped their target price on Ingredion from $155.00 to $150.00 and set an "equal weight" rating for the company in a report on Wednesday, February 5th. UBS Group set a $155.00 target price on Ingredion in a report on Tuesday, April 22nd. Wall Street Zen upgraded Ingredion from a "buy" rating to a "strong-buy" rating in a report on Monday. Finally, Oppenheimer dropped their target price on Ingredion from $167.00 to $155.00 and set an "outperform" rating for the company in a report on Tuesday, April 22nd. Three equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $152.20.
Check Out Our Latest Research Report on Ingredion
Insider Buying and Selling at Ingredion
In related news, SVP Larry Fernandes sold 2,400 shares of Ingredion stock in a transaction on Wednesday, May 7th. The stock was sold at an average price of $135.82, for a total transaction of $325,968.00. Following the completion of the transaction, the senior vice president now directly owns 31,996 shares of the company's stock, valued at approximately $4,345,696.72. The trade was a 6.98% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 2.30% of the company's stock.
Ingredion Stock Performance
Shares of Ingredion stock opened at $137.28 on Friday. The business has a 50-day moving average of $132.84 and a 200 day moving average of $135.86. Ingredion Incorporated has a 12 month low of $111.54 and a 12 month high of $155.44. The stock has a market capitalization of $8.83 billion, a price-to-earnings ratio of 14.14, a price-to-earnings-growth ratio of 1.03 and a beta of 0.73. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.62 and a quick ratio of 1.69.
Ingredion (NYSE:INGR - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $2.97 EPS for the quarter, beating analysts' consensus estimates of $2.44 by $0.53. The company had revenue of $1.81 billion during the quarter, compared to analysts' expectations of $1.84 billion. Ingredion had a return on equity of 18.62% and a net margin of 8.71%. Ingredion's revenue for the quarter was down 3.7% on a year-over-year basis. During the same period last year, the business posted $2.08 EPS. As a group, sell-side analysts forecast that Ingredion Incorporated will post 11.14 earnings per share for the current year.
Ingredion Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 22nd. Shareholders of record on Tuesday, July 1st will be paid a $0.80 dividend. This represents a $3.20 annualized dividend and a dividend yield of 2.33%. Ingredion's dividend payout ratio (DPR) is currently 33.76%.
Ingredion Profile
(
Free Report)
Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.
Read More
Want to see what other hedge funds are holding INGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingredion Incorporated (NYSE:INGR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ingredion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ingredion wasn't on the list.
While Ingredion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.